| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
|
|
|
|||||||
|
|||||||||
ORIGINAL RESEARCH COMMUNICATIONS |
1 From the MRC Biostatistics Unit, Institute of Public Health, Robinson Way, Cambridge, United Kingdom (CA and NED); the Metabolic Bone Unit, Addenbrooke's Hospital, Cambridge, United Kingdom (JEC); the Department of Biochemistry, Royal Marsden Hospital, London (MD); and the MRC Dunn Human Nutrition Unit, Cambridge, United Kingdom (SAB)
Background: Isoflavone phytoestrogen therapy has been proposed as a natural alternative to hormone replacement therapy (HRT). HRT has a beneficial effect on bone, but few trials in humans have investigated the effects of isoflavones on bone.
Objective: The objective of the study was to determine the effect on bone density of a red clover-derived isoflavone supplement that provided a daily dose of 26 mg biochanin A, 16 mg formononetin, 1 mg genistein, and 0.5 mg daidzein for 1 y. Effects on biochemical markers of bone turnover and body composition were also studied.
Design: Women aged 49-65 y (n = 205) were enrolled in a double-blind, randomized, placebo-controlled trial; 177 completed the trial. Bone density, body composition, bone turnover markers, and diet were measured at baseline and after 12 mo.
Results: Loss of lumbar spine bone mineral content and bone mineral density was significantly (P = 0.04 and P = 0.03, respectively) lower in the women taking the isoflavone supplement than in those taking the placebo. There were no significant treatment effects on hip bone mineral content or bone mineral density, markers of bone resorption, or body composition, but bone formation markers were significantly increased (P = 0.04 and P = 0.01 for bone-specific alkaline phosphatase and N-propeptide of collagen type I, respectively) in the intervention group compared with placebo in postmenopausal women. Interactions between treatment group and menopausal status with respect to changes in other outcomes were not significant.
Conclusion: These data suggest that, through attenuation of bone loss, isoflavones have a potentially protective effect on the lumbar spine in women.
Key Words: Isoflavones • phytoestrogens • bone density • randomized controlled trial • body composition • estrogen and vitamin D receptor polymorphisms
This article has been cited by other articles:
|
|
 |
|
  T. J Powles, A. Howell, D G. Evans, E. V McCloskey, S. Ashley, R. Greenhalgh, J. Affen, L. A. Flook, and A. Tidy Red clover isoflavones are safe and well tolerated in women with a family history of breast cancer Menopause Int, March 1, 2008; 14(1): 6 - 12. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 K. A. Nelson, G. E. Rottinghaus, and T. E. Nelson Effect of Lactofen Application Timing on Yield and Isoflavone Concentration in Soybean Seed Agron. J., April 4, 2007; 99(3): 645 - 649. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 D. Bunout, G. Barrera, L. Leiva, V. Gattas, M. P. de la Maza, F. Haschke, P. Steenhout, P. Klassen, C. Hager, E. Offord, et al. Effect of a Nutritional Supplementation on Bone Health in Chilean Elderly Subjects with Femoral Osteoporosis J. Am. Coll. Nutr., June 1, 2006; 25(3): 170 - 177. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. M. Whelan, T. M Jurgens, and S. K Bowles Natural Health Products in the Prevention and Treatment of Osteoporosis: Systematic Review of Randomized Controlled Trials Ann. Pharmacother., May 1, 2006; 40(5): 836 - 849. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 T. Clavel, M. Fallani, P. Lepage, F. Levenez, J. Mathey, V. Rochet, M. Serezat, M. Sutren, G. Henderson, C. Bennetau-Pelissero, et al. Isoflavones and Functional Foods Alter the Dominant Intestinal Microbiota in Postmenopausal Women J. Nutr., December 1, 2005; 135(12): 2786 - 2792. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 X. Zhang, X.-O. Shu, H. Li, G. Yang, Q. Li, Y.-T. Gao, and W. Zheng Prospective Cohort Study of Soy Food Consumption and Risk of Bone Fracture Among Postmenopausal Women Arch Intern Med, September 12, 2005; 165(16): 1890 - 1895. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C. M. Weaver and J. M. K. Cheong Soy Isoflavones and Bone Health: The Relationship Is Still Unclear J. Nutr., May 1, 2005; 135(5): 1243 - 1247. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Messina Western soy intake is too low to produce health effects Am. J. Clinical Nutrition, August 1, 2004; 80(2): 528 - 529. [Full Text] [PDF]
|
|
|
|
|
|
C. Atkinson, W. Oosthuizen, S. Scollen, A. Loktionov, N. E. Day, and S. A. Bingham Modest Protective Effects of Isoflavones from a Red Clover-Derived Dietary Supplement on Cardiovascular Disease Risk Factors in Perimenopausal Women, and Evidence of an Interaction with ApoE Genotype in 49-65 Year-Old Women J. Nutr., July 1, 2004; 134(7): 1759 - 1764. [Abstract] [Full Text]
|
|
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
